125 related articles for article (PubMed ID: 9192246)
21. Coronary haemodynamics and vasodilatory profile of a potassium channel opener in patients with coronary artery disease.
Suryapranata H
Eur Heart J; 1993 Jul; 14 Suppl B():16-21. PubMed ID: 8370366
[TBL] [Abstract][Full Text] [Related]
22. Primary coronary angioplasty in acute myocardial infarction: clinical correlates of the 'no reflow' phenomenon.
Marzilli M; Gliozheni E; Marraccini P; Fedele S
Int J Cardiol; 1998 May; 65 Suppl 1():S23-8. PubMed ID: 9706823
[TBL] [Abstract][Full Text] [Related]
23. Effective and safe dose of intracoronary nicorandil in man.
Miwa K; Igawa A; Yamanishi K; Fujita M; Inouc H
Jpn Circ J; 1995 Nov; 59(11):736-44. PubMed ID: 8747763
[TBL] [Abstract][Full Text] [Related]
24. Cardioprotective effects of nicorandil.
Gross GJ; Auchampach JA; Maruyama M; Warltier DC; Pieper GM
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S22-8. PubMed ID: 1282172
[TBL] [Abstract][Full Text] [Related]
25. [Beneficial effects of nicorandil on myocardial no-reflow state in a mini-swine model of acute myocardial infarction and reperfusion].
Zhao JL; Yang YJ; You SJ; Jing ZC; Wu YJ; Yang WX; Meng L; Tian Y; Chen JL; Gao RL; Chen ZJ
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2005 Jul; 17(7):421-5. PubMed ID: 16004786
[TBL] [Abstract][Full Text] [Related]
26. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
[TBL] [Abstract][Full Text] [Related]
27. [Potassium channel activators: hemodynamic effects at the systemic and coronary level].
Perrone Filardi P; Chiariello M
Cardiologia; 1995 Dec; 40(12 Suppl 1):87-9. PubMed ID: 8998787
[No Abstract] [Full Text] [Related]
28. Assessment of no-reflow phenomenon after acute myocardial infarction with harmonic angiography and intravenous pump infusion with Levovist: comparison with intracoronary contrast injection.
Agati L; Funaro S; Bilotta F
J Am Soc Echocardiogr; 2001 Aug; 14(8):773-81. PubMed ID: 11490325
[TBL] [Abstract][Full Text] [Related]
29. Safety profile of an anti-anginal agent with potassium channel opening activity: an overview.
Roland E
Eur Heart J; 1993 Jul; 14 Suppl B():48-52. PubMed ID: 8370373
[TBL] [Abstract][Full Text] [Related]
30. Coronary microvascular response to intracoronary administration of nicorandil.
Hongo M; Takenaka H; Uchikawa S; Nakatsuka T; Watanabe N; Sekiguchi M
Am J Cardiol; 1995 Feb; 75(4):246-50. PubMed ID: 7832132
[TBL] [Abstract][Full Text] [Related]
31. Nicorandil reduces myocardial infarct size by opening the K(ATP) channel in rabbits.
Ohno Y; Minatoguchi S; Uno Y; Kariya T; Arai M; Yamashita K; Fujiwara T; Fujiwara H
Int J Cardiol; 1997 Dec; 62(3):181-90. PubMed ID: 9476676
[TBL] [Abstract][Full Text] [Related]
32. Limitation of myocardial infarct size by nicorandil after sustained ischemia in pigs.
Galiè N; Guarnieri C; Ussia GP; Zimarino M; Traini AM; Parlangeli R; Vaona I; Branzi A; Magnani B
J Cardiovasc Pharmacol; 1995 Sep; 26(3):477-84. PubMed ID: 8583791
[TBL] [Abstract][Full Text] [Related]
33. Study of the efficacy of nicorandil in patients with ischaemic heart disease using Exercise-T1-201 myocardial tomography.
Yamazaki J; Ohsawa H; Uchi T; Iida M; Nakano H; Hosoi H; Morishita T; Yabe Y; Koyama N; Komatsu H
Eur J Clin Pharmacol; 1993; 44(3):211-7. PubMed ID: 8491233
[TBL] [Abstract][Full Text] [Related]
34. An ATP-sensitive potassium (KATP) channel opener, nicorandil, lowers the threshold for ischemic preconditioning in barbital-anesthetized dogs.
Mizumura T; Saito S; Ozawa Y; Kanmatsuse K; Gross GJ
Heart Vessels; 1997; Suppl 12():175-7. PubMed ID: 9476575
[TBL] [Abstract][Full Text] [Related]
35. Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo.
Imagawa J; Baxter GF; Yellon DM
J Cardiovasc Pharmacol; 1998 Jan; 31(1):74-9. PubMed ID: 9456280
[TBL] [Abstract][Full Text] [Related]
36. Comparative effects of nicorandil, a nicotinamide nitrate derivative, and nifedipine on myocardial reperfusion injury in dogs.
Gross GJ; Warltier DC; Hardman HF
J Cardiovasc Pharmacol; 1987 Nov; 10(5):535-42. PubMed ID: 2447402
[TBL] [Abstract][Full Text] [Related]
37. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
38. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
[TBL] [Abstract][Full Text] [Related]
39. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
Kato K
Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
[TBL] [Abstract][Full Text] [Related]
40. [Successful treatment of intraoperative myocardial ischemia with nicorandil].
Kawamura S; Hayashida M; Orii R; Sawamura S; Komatsu K; Ito N; Kuzumi E; Hanaoka K
Masui; 1997 Apr; 46(4):531-7. PubMed ID: 9128027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
